191 related articles for article (PubMed ID: 11465634)
1. The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors.
Millan MJ; Newman-Tancredi A; Quentric Y; Cussac D
Psychopharmacology (Berl); 2001 Jun; 156(1):58-62. PubMed ID: 11465634
[TBL] [Abstract][Full Text] [Related]
2. Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels.
Kuzhikandathil EV; Oxford GS
Mol Pharmacol; 2002 Jul; 62(1):119-26. PubMed ID: 12065762
[TBL] [Abstract][Full Text] [Related]
3. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
4. (+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Izenwasser S; Geter-Douglass B; Witkin JM; Newman AH
J Med Chem; 1995 Oct; 38(21):4284-93. PubMed ID: 7473556
[TBL] [Abstract][Full Text] [Related]
5. An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletion.
Cussac D; Newman-Tancredi A; Quentric Y; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):221-3. PubMed ID: 10685880
[TBL] [Abstract][Full Text] [Related]
6. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
7. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine.
Cussac D; Pasteau V; Millan MJ
Eur J Pharmacol; 2004 Feb; 485(1-3):111-7. PubMed ID: 14757130
[TBL] [Abstract][Full Text] [Related]
9. Activation of adenosine A1 receptor modulates dopamine D1 receptor activity in stably cotransfected human embryonic kidney 293 cells.
Cao Y; Sun WC; Jin L; Xie KQ; Zhu XZ
Eur J Pharmacol; 2006 Oct; 548(1-3):29-35. PubMed ID: 16956604
[TBL] [Abstract][Full Text] [Related]
10. Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptors.
Leonard SK; Ferry-Leeper P; Mailman RB
Brain Res; 2006 Oct; 1117(1):25-37. PubMed ID: 16962565
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
12. Antagonist properties of the novel antipsychotic, S16924, at cloned, human serotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol.
Cussac D; Newman-Tancredi A; Nicolas JP; Boutin JA; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):549-54. PubMed ID: 10832610
[TBL] [Abstract][Full Text] [Related]
13. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
[TBL] [Abstract][Full Text] [Related]
14. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
15. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Ramos M; Goñi-Allo B; Aguirre N
Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
[TBL] [Abstract][Full Text] [Related]
16. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain.
Jin LQ; Goswami S; Cai G; Zhen X; Friedman E
J Neurochem; 2003 Apr; 85(2):378-86. PubMed ID: 12675914
[TBL] [Abstract][Full Text] [Related]
17. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
18. Functional differentiation of multiple dopamine D1-like receptors by NNC 01-0012.
Sugamori KS; Hamadanizadeh SA; Scheideler MA; Hohlweg R; Vernier P; Niznik HB
J Neurochem; 1998 Oct; 71(4):1685-93. PubMed ID: 9751203
[TBL] [Abstract][Full Text] [Related]
19. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
Rosenzweig-Lipson S; Zhang J; Mazandarani H; Harrison BL; Sabb A; Sabalski J; Stack G; Welmaker G; Barrett JE; Dunlop J
Brain Res; 2006 Feb; 1073-1074():240-51. PubMed ID: 16430874
[TBL] [Abstract][Full Text] [Related]
20. Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain.
Undie AS; Friedman E
Eur J Pharmacol; 1992 Aug; 226(4):297-302. PubMed ID: 1327844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
